Procept BioRobotics (Nasdaq:PRCT) announced that it received FDA investigational device exemption (IDE) for a second ...
Analysts' ratings for PROCEPT BioRobotics (NASDAQ:PRCT) over the last quarter vary from bullish to bearish, as provided by 4 analysts. The table below provides a concise overview of recent ratings by ...
In the latest quarter, 6 analysts provided ratings for PROCEPT BioRobotics (NASDAQ:PRCT), showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results